Literature DB >> 24132477

Use of dodecahedron "VLPs" as an alternative to the whole adenovirus.

Pascal Fender1.   

Abstract

During human adenovirus type 3 (Ad3) infection, an excess of penton base and fiber proteins are produced. These form dodecahedral particles composed of 12 pentamers of penton base and 12 trimers of fiber protein. Beside this "natural" expression, the adenovirus dodecahedron can be expressed in the heterologous baculovirus system in two forms: a fiber-devoid dodecahedron made only of 12 penton bases (called base-dodecahedron: Bs-Dd) and the fiber-containing dodecahedron (called penton dodecahedron: Pt-Dd). These particles partly mimic the adenoviral cellular entry pathway but are devoid of genetic information making them an unusual tool for basic research or applications. We report here how these particles are expressed and purified, the labeling method for trafficking studies as well as their use in molecular interaction studies. The potential of these particles for biotechnological applications is under evaluation, making their study a "niche" along side traditional adenoviral vectors.

Entities:  

Mesh:

Year:  2014        PMID: 24132477     DOI: 10.1007/978-1-62703-679-5_4

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  2 in total

1.  HER3-targeted protein chimera forms endosomolytic capsomeres and self-assembles into stealth nucleocapsids for systemic tumor homing of RNA interference in vivo.

Authors:  Felix Alonso-Valenteen; Sayuri Pacheco; Dustin Srinivas; Altan Rentsendorj; David Chu; Jay Lubow; Jessica Sims; Tianxin Miao; Simoun Mikhael; Jae Youn Hwang; Ravinder Abrol; Lali K Medina Kauwe
Journal:  Nucleic Acids Res       Date:  2019-12-02       Impact factor: 16.971

2.  Elicitation of potent SARS-CoV-2 neutralizing antibody responses through immunization with a versatile adenovirus-inspired multimerization platform.

Authors:  Christopher Chevillard; Axelle Amen; Solène Besson; Dalil Hannani; Isabelle Bally; Valentin Dettling; Evelyne Gout; Christophe J Moreau; Marlyse Buisson; Salomé Gallet; Daphna Fenel; Emilie Vassal-Stermann; Guy Schoehn; Pascal Poignard; Marie-Claire Dagher; Pascal Fender
Journal:  Mol Ther       Date:  2022-02-10       Impact factor: 12.910

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.